RG
BMY.RT

Redmile Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Redmile Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,467,000
Closed -$8.83M – 92
2020
Q2 		$8.83M Buy
2,467,000
+78,000
+3% +$279K 0.16% 69
2020
Q1 		$9.08M Buy
+2,389,000
New +$9.08M 0.25% 56